InsidersTradesSigma
Explore the detailed record of transactions filed by Sundaram Senthil Vel, Chairman & CEO. Officer active across 1 companies, notably Terns Pharmaceuticals, Inc.. Cumulatively, 1 filings have been recorded. Total volume traded: €10k. The latest transaction was disclosed on 31 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
1 of 1 declaration
Senthil Vel Sundaram is the Chairman & CEO of Terns Pharmaceuticals, Inc. He is responsible for the strategic direction of the company and the management of its operations. Senthil brings expertise in business development and innovation to support the company's growth.